Next Generation Sequencing Market Expected to Grow US$ 7,527.0 Mn by 2021 at a CAGR of 16.02%

SA-BRC’s Global Next Generation Sequencing (NGS) Market report is a unique report with central focus on key players and emerging technologies. The report provides holistic view of next generation sequencing instruments, reagents and consumables, and services. This is a 360 degree study covering key players, application, end-users and geographical analysis.

The global next generation sequencing market was valued at US$ 3,509.6 million in 2016 and is expected to reach US$ 7,527.0 million by 2021 growing at a compounded annual growth rate (CAGR) of 16.02%. At least five companies are currently developing novel NGS technology which may commercialize during the forecast period. Although currently the market is dominated by Illumina, various other companies are investing in development of novel methods for efficient and cost effective sequencing. The next generation sequencing market has witnessed series of acquisitions and strategic agreements in the recent past and has become more competitive. North America would dominate the overall market; however rapid growth would be seen in the Asia Pacific and Europe.

Key players mentioned in the next generation sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc., Oxford Nanopore, Pacific Biosciences, Qiagen N.V., Roche Sequencing, Stratos Genomics, GnuBio and others.

Key Aspects in Global Next Generation Sequencing (NGS) Market report:

The report segments the next generation sequencing market as follows:

Market by Key players
Illumina
Thermo Fisher Scientific
Pacific Biosciences
Roche Sequencing
Oxford Nanopore
Qiagen
Others (Complete Genomics, Genapsys, Lasergen, Nabsys 2.0, Quantum Biosciences, Stratos Genomics)
Market by Applications
Diagnosis
Genome Sequencing
Biopharmaceutical Research
Food and Agriculture
Others
Report Sample@ http://www.sa-brc.com/Global-Next-Generation-Sequencing-Market-Assessment--Forecast-2017---2021/sample32

Market by End-users
Universities, Academia and Research Institutes
NGS Service Providers
Others
Market by Geography
North America
Europe
Asia Pacific
Latin America
Middle-East and Africa
For each of these segments and sub-segments, market estimates have been provided from 2015 to 2021 (historic data for 2015 and 2016, and forecast from 2017 to 2021)

The next generation sequencing services market report provides extensive analysis by Key Players:

The report provides information on next generation sequencing instruments product portfolio, recent developments and market overview. The ‘others’ segment provides market estimation and forecast for pipeline technologies that are expected to launch during the forecast period. Market for each of the key players is further segmented for instruments and reagents.

The next generation sequencing services market is further segmented into Applications:

This segment provides details on factors responsible for implementation of NGS technology in various applications. The next generation sequencing services market is segmented into diagnosis, genome analysis, biopharmaceutical research, food and agriculture and other applications.

Next generation sequencing market from End-Users point-of-view:

This segment provides insights to trends in adoption of NGS technology by the end-users. The next generation sequencing instruments, reagents and consumables market is segmented into Universities and Academia, Research Institutions, NGS Service Providers and Others.

Click For TOC@ http://www.sa-brc.com/report/Global-Next-Generation-Sequencing-Market-Assessment--Forecast-2017---2021/32

Geography deep-dive analysis:

This segment provides an overview of the PESTL analysis of each geographical region. Major regions covered in to the report include North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). This segment is further segmented into reagents and consumables, services, and instruments.

Other aspects of the next generation sequencing market discussed in the report:

The report explains major factors driving and restraining the overall market. Lucrative opportunities that company can bank on are also explained in the report. Recent development, patent litigations, mergers, acquisitions, strategic agreements and regulatory updates are also provided in the report.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.